Skip to main content
Fig. 11 | BMC Medicine

Fig. 11

From: ‘Fit-for-purpose?’ – challenges and opportunities for applications of blockchain technology in the future of healthcare

Fig. 11

Kamal Obbad is CEO and co-founder of Nebula Genomics. He attended Harvard University, where he conducted research on neurological and embryological development. After Harvard, Kamal joined Google and worked within the research and machine intelligence organization. He is a recipient of the Gates-Cambridge Fellowship for the pursuance of graduate studies in advanced computer science

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us